SCHEMBL8285261

SCHEMBL8285261

CCOc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
CSF1R P07333 1/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 1/20 0.37
PDE11A Q9HCR9 2/20 0.36
CACNA2D1 P54289 1/20 0.35
ACSS2 Q9NR19 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287576 0.89 GSK3B (0.39) GSK3BMAPTPDE11ACDK4CCND1
SCHEMBL8285333 0.88 GSK3B (0.36) GSK3BPDE11ACDK4CCND1CCND2
SCHEMBL8287248 0.88 MEN1 (0.43) CSF1RMAPTKDM4EHSD17B10MAT2A
SCHEMBL8287459 0.88 GABRP (0.38) GSK3BMAPTPDE11AGABRPGABRD
SCHEMBL8287240 0.87 HTT (0.41) GSK3BCSF1RMAPTKDM4EPDE11A
SCHEMBL8285329 0.87 GSK3B (0.40) GSK3BCSF1RKDM4EPDE11ACDK4
SCHEMBL8285335 0.86 MAT2A (0.37) GSK3BCSF1RPDE11ACDK4CCND1
SCHEMBL8285316 0.86 PDE11A (0.40) GSK3BMAPTPDE11ACDK4CCND1
SCHEMBL8287241 0.86 RAB9A (0.40) GSK3BCSF1RKDM4EALDH1A1SMN1; SMN2
SCHEMBL8287482 0.86 GSK3B (0.40) GSK3BMAPTPDE11AGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed